Number of individuals aged 5-40 years with a diagnosis of mild, moderate, or severe persistent Number of asthma and Prescription of individuals aged DEC† DEC† DEC† prescribed either long-term drug 5-40 years with a NA NA NA ROR: 0.81 ROR: 0.56 ROR: 0.60 therapy for the preferred diagnosis of mild, [0.74-0.89] [0.41-0.76] [0.50-0.71] Q04 asthma long‐term moderate, or control severe persistent medication asthma (inhaled corticosteroid) or an acceptable alternative treatment Number of individuals aged Persistence 18 and Number of Q05 with ACE older with a individuals aged DEC DEC† INC inhibitor or diagnosis of 18 years and older NA NA NA ROR: 0.95 ROR: 0.73 ROR: 1.12 ARB therapy diabetes and with a diagnosis [0.82-1.11] [0.61-0.86] [0.94-1.33] for diabetes persistent with of diabetes ACE inhibitor or ARB therapy Number of children 3–6 Well-care Number of DEC DEC* NC INC INC years old with visits for children aged NA Δ: -0.02 Δ: -0.05 Δ: 0.00 Δ: 0.02 Δ: 0.01 Q06 one or more children 3-6 years [SE: 0.02] [SE: 0.02] [SE: 0.02] [SE: 0.03] [SE: 0.02] well–child visits to any PCP
Q04 Prescription of long-term drug therapy for asthma Number of individuals aged 5-40 years with a diagnosis of mild, moderate, or severe persistent asthma and prescribed either the preferred long‐term control medication (inhaled corticosteroid) or an acceptable alternative treatment Number of individuals aged 5-40 years with a diagnosis of mild, moderate, or severe persistent asthma DEC† ROR: 0.81 [0.74-0.89] DEC† ROR: 0.56 [0.41-0.76] DEC† ROR: 0.60 [0.50-0.71] NA NA NA Q05 Persistence with ACE inhibitor or ARB therapy for diabetes Number of individuals aged 18 and older with a diagnosis of diabetes and persistent with ACE inhibitor or ARB therapy Number of individuals aged 18 years and older with a diagnosis of diabetes INC ROR: 1.12 [0.94-1.33] DEC ROR: 0.95 [0.82-1.11] DEC† ROR: 0.73 [0.61-0.86] NA NA NA Q06 Well-care visits for children Number of children 3–6 years old with one or more well–child visits to any PCP Number of children aged 3-6 years DEC Δ: -0.02 [SE: 0.02] NA DEC* Δ: -0.05 [SE: 0.02] NC Δ: 0.00 [SE: 0.02] INC Δ: 0.02 [SE: 0.03] INC Δ: 0.01 [SE: 0.02]
MLR_2018_01_18_HARRIS_MDC-D-17-00555R1_SDC1.docx